[1]
G. Weng, W. Fang, Y. Lin, L. Chen, and W. Su, “Clinical effect of anlotinib in combination with docetaxel in treating advanced non-small cell lung cancer: Anlotinib in combination with docetaxel in NSCLC”, Cell Mol Biol (Noisy-le-grand), vol. 70, no. 4, pp. 212–216, Apr. 2024.